TrialClinical pharmacology in drug development2021

First-in-Human Studies of MW01-6-189WH, a Brain-Penetrant, Antineuroinflammatory Small-Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers.

Linda J Van Eldik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.